Evil Knievil: Watchstone still a buy
0 mins. to read
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
Latest from our blog
Read more
The best property investment trusts
11 mins. to read
REITs offer the prospect of capital growth and a secure and rising income. Nick Sudbury looks at some of the best ways to gain exposure to these trusts.
Evil Diaries
Evil Knievil: Watchstone still a buy
0 mins. to read
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
Evil Knievil: Faites vos jeux
1 mins. to read
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
Financial News
Read more
Hikma Pharmaceuticals gets a shot in the arm from new line
0 mins. to read
Hikma Pharmaceuticals saw its share price climb by 1.96% after it announced the launch of prefilled syringe products in the United States.
Rosslynn Data Technologies lifted by revenue growth
0 mins. to read
The price of shares in Rosslynn Data Technologies climbed 6.33% after its revenues rose by 8.3% during the year ended 30th April.
Equities
Read more
Why JD Sports Fashion can buck the retail trend
2 mins. to read
Robert Stephens discusses why JD Sports Fashion has the right strategy to deliver capital growth over the long term.
Small cap round up: featuring Eddie Stobart, Chemring and Futura Medical
8 mins. to read
In this weekly summary, Mark Watson-Mitchell updates his readers on previous company profiles and other news of interest from the exciting world of small cap stocks…
Trading
Read more
Is silver’s slump finally over?
5 mins. to read
Veteran trader David Jones looks at silver and how investors can profit from a recovery in the price of this precious metal.
Is this the start of a new bull market for gold?
4 mins. to read
As gold springs back to life, David Jones investigates whether this is a time to take profits or to prepare for a much bigger move over the longer term.
Economics & Markets
Read more
What the West can learn from Japan’s wilderness years
7 mins. to read
The West has learnt nothing from the experience of Japan’s lost two decades. That could prove to be painfully expensive.
What kind of remain do Remainers really want?
14 mins. to read
Remainers argue that no one voted for no-deal. But exactly what kind of remain did Remainers vote for? Victor Hill inquires.
Commodities
Read more
Solgold shares have stalled – here’s why…
7 mins. to read
Solgold, my best tip – up from under 3p in 2015 to a 45p peak in 2017 – has been up and down ever since, like the proverbials in Klondike mining towns.
Why I’m buying Shanta and keeping an eye on Kefi but avoiding Hummingbird
8 mins. to read
With gold on the ascent, John Cornford explains why he’s buying Shanta and keeping a close eye on Kefi but avoiding Hummingbird.
Funds & Investment Trusts
Read more
The best property investment trusts
11 mins. to read
REITs offer the prospect of capital growth and a secure and rising income. Nick Sudbury looks at some of the best ways to gain exposure to these trusts.
New IPO: JPMorgan Global Core Real Assets
2 mins. to read
JP Morgan Global Core Real Assets is a new investment trust that provides exposure to a global portfolio of real estate, infrastructure and transportation assets.
Brexit
Read more
What kind of remain do Remainers really want?
14 mins. to read
Remainers argue that no one voted for no-deal. But exactly what kind of remain did Remainers vote for? Victor Hill inquires.
Brexit – a guide for the perplexed
25 mins. to read
What are the chances that Brexit will be postponed or even reversed altogether? And if it does take place – which type of Brexit will it be and who will be the winners and losers in the corporate world? Victor Hill investigates.
Partner Content
Read more
How the regulators can make or break an investment
8 mins. to read
Regulations can often be positive for industry incumbents, but investors need to be wary of regulator change, explains Ben Lofthouse of Henderson International Income Trust.
Novo Nordisk – the anatomy of a good company
7 mins. to read
Jamie Ross, fund manager of Henderson EuroTrust, explains the rationale behind the inclusion of the Danish pharmaceutical company Novo Nordisk in his portfolio.